An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to evaluate the
incidence of serious adverse drug reactions when initiating or switching to insulin therapy
with NovoMix® 30 in subjects with type 2 diabetes under normal clinical practice conditions